As we demonstrated KPNB1 as an important modulator of wild-type and polyQ-expanded ataxin-3 protein levels, we sought to investigate its endogenous levels in animal models of MJD. The gene discussed is KPNB1; the disease is Spinocerebellar ataxia type 3.